Drugs used in less than 5% of cases were subcutaneous fondaparinux (4.4%), subcutaneous dalteparin (0.3%), and i.v. enoxaparin (0.1%). The most common indications for anticoagulant use among the ...
Delayed-type hypersensitivity to subcutaneous enoxaparin ... Boehncke WH: Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003 ...
Delayed-type hypersensitivity to subcutaneous enoxaparin ... Boehncke WH: Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003 ...